HLC Child + Multi

Child-specific chewable multivitamin and probiotic.

HLC child + multi is a delicious, natural blackcurrant flavoured one-a-day chewable tablet that provides an easy and enjoyable way for children to obtain daily multivitamins to support overall health and probiotics to contribute to a natural healthy gut flora. While refrigeration will extend the shelf-life of probiotics, ambient-safe HLC child + multi provides a choice for practitioners who are concerned about product viability but do not have refrigeration facilities.

Probiotic with multivitamins
Contains 12.5 billion CFU*/serving of clinically proven probiotic strains.

Unique manufacturing process
Utilized to help maintain high potency probiotic stability in combination with multivitamins.

Ambient-Safe
Manufactured to allow for ambient temperature (20-25?C) storage and 2 year shelf-life without compromising product stability and still meet or exceed label claims.

Great child-appeal increases compliance
Natural blackcurrant flavour.

Serving Size: 1 Tablet
Servings Per Container: 30

Active Ingredients:

• Vitamin A (vitamin A acetate) . 400 mcg RAE/1333 IU
• Vitamin C (ascorbic acid) . 100 mg
• Vitamin D (cholecalciferol) . 12.5 mcg / 500 IU
• Vitamin E (d-alpha tocopheryl acetate) . 20 mg AT / 30 IU
• Vitamin K1 (phylloquinone). 25 mcg
• Thiamine (thiamine mononitrate). 1.4 mg
• Riboflavin. 1.6 mg
• Niacinamide. 7.5 mg
• Vitamin B6 (pyridoxine hydrochloride). 2 mg
• Folate (folic acid). 200 mcg
• Vitamin B12 (cyanocobalamin). 50 mcg
• Biotin. 150 mcg
• Pantothenic acid (calcium d-pantothenate). 6 mg
• HLC Consortium. 12.5 billion viable cells
  Lactobacillus acidophilus (CUL-60)
  Lactobacillus acidophilus (CUL-21)
  Bifidobacterium bifidum (CUL-20)
  Bifidobacterium animalis subsp. lactis (CUL-34)

Inactive Ingredients: Sorbitol, xylitol, natural blackcurrant flavour, silica, vegetable magnesium stearate, sucralose

Recommended Dosage:
Children (4 years and older): One tablet taken once daily or as professionally directed.

Risk information: If you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain; or if you have an immune-compromised condition, do not use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner. If you are taking blood thinners, consult your healthcare practitioner prior to use.

Seroyal research-driven probiotic therapies::

• Clinically proven in randomized, double-blind, placebo-controlled adult human trials at 25 billion CFU? to:
  - Reduce symptoms of Irritable Bowel Syndrome (IBS)1
  - Prevent intestinal microflora disruption post antibiotics2, 3
  - Reduce the incidence of C. difficile associated diarrhoea (Pilot study)4
• P roprietary non-pathogenic human-sourced microflora bacterial strains have:
  - Strong epithelial adherence
  - Naturally high tolerance to stomach acid
• Ambient-Safe
  - Manufacturing allows for ambient temperature (20-25?C) storage and 2 year shelf-life without compromising product stability and still meet or exceed label claims

References:

1. Williams EA, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 2009; 29(1): 97-103.
2. Plummer SF, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005; 26(1); 69-74.
3. Madden JA, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005; (6): 1091-7.
4. Plummer S, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7(1):59-62.